KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 1 filers reported holding KALA PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $11,000 | -26.7% | 3,000 | -25.0% | 0.00% | – |
| Q3 2019 | $15,000 | -60.5% | 4,000 | -33.3% | 0.00% | – |
| Q2 2019 | $38,000 | -7.3% | 6,000 | +20.0% | 0.00% | – |
| Q1 2019 | $41,000 | +720.0% | 5,000 | +900.0% | 0.00% | – |
| Q3 2018 | $5,000 | -37.5% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $8,000 | +300.0% | 500 | +400.0% | 0.00% | – |
| Q4 2017 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,483,343 | $5,474,000 | 5.28% |
| Polaris Venture Management Co. V, L.L.C. | 565,289 | $2,086,000 | 1.52% |
| Ikarian Capital, LLC | 1,023,431 | $3,776,000 | 0.61% |
| RA Capital Management | 4,537,478 | $16,743,000 | 0.51% |
| Ikarian Capital, LLC | 395,500 | $1,459,000 | 0.24% |
| Orbimed Advisors | 3,447,840 | $12,723,000 | 0.18% |
| Sofinnova Investments, Inc. | 664,641 | $2,453,000 | 0.18% |
| PURA VIDA INVESTMENTS, LLC | 533,287 | $1,968,000 | 0.17% |
| BANCO BILBAO VIZCAYA ARGENTARIA, S.A. | 1,401,110 | $5,170,000 | 0.16% |
| HARBOURVEST PARTNERS LLC | 99,186 | $366,000 | 0.15% |